J. Toro

Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype.

J. Andersson, S. Hoffner, J. Toro, 2006, Microbes and infection.

Assessment of the activity of selected Indian medicinal plants against Mycobacterium tuberculosis: a preliminary screening using the microplate Alamar Blue Assay.

S. Hoffner, J. Toro, P. Tetali, 2012 .

Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis.

B. Petrini, S. Hoffner, J. Toro, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Glycine and alanine dehydrogenase activities are catalyzed by the same protein in Mycobacterium smegmatis: upregulation of both activities under microaerophilic adaptation.

R. Jayaraman, S. Hoffner, J. Toro, 2002, Canadian journal of microbiology.

Dynamics of Extensive Drug Resistance Evolution of Mycobacterium tuberculosis in a Single Patient During 9 Years of Disease and Treatment

D. Andersson, S. Hoffner, L. Sandegren, 2020, The Journal of infectious diseases.

Rifampin Heteroresistance in Mycobacterium tuberculosis Cultures as Detected by Phenotypic and Genotypic Drug Susceptibility Test Methods

L. Rigouts, D. Hillemann, S. Hoffner, 2013, Journal of Clinical Microbiology.

Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis

P. Juréen, S. Hoffner, J. Toro, 2008, Antimicrobial Agents and Chemotherapy.

Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study

D. Hillemann, D. Cirillo, E. Borroni, 2015, Journal of Clinical Microbiology.

Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid

A. Witney, S. Niemann, Juliano Timm, 2022, The Journal of antimicrobial chemotherapy.